Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy
Information source: Prince of Songkla University
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Postoperative Nausea and Vomiting
Intervention: Dexamethasone (Drug); Ondansetron (Drug); Dimenhydrinate (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: Prince of Songkla University Official(s) and/or principal investigator(s):
Thanyamon Asampinwat, MD, Principal Investigator, Affiliation: Anesthesiology department, Faculty of Medicine, Prince of Songkla University Thailand
Summary
The purpose of this study is to compare the incidence of Postoperative nausea and vomiting
between the intervention group who received multimodal antiemetic management and the control
group who did not get this protocol.
Clinical Details
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Primary outcome: Incidence of PONV in ambulatory gynecologic laparoscopy
Eligibility
Minimum age: 18 Years.
Maximum age: 45 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Ambulatory gynecologic laparoscopy
- Age 18-45 years
- ASA class 1-2
Exclusion Criteria:
- The patients who take opioid, steroid, pyschotics or antiemetic drug within 24 hours
before surgery
- History of antiemetic, anesthetic and analgesic drugs allergy
- Pregnancy or breast feeding
- Body mass index >34 kg/square metre
Locations and Contacts
Anesthesiology Department, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand
Additional Information
Starting date: March 2008
Last updated: July 29, 2012
|
